Thank you, Mr. Chair, and thank you to the presenters for the information.
I don't know if I should say it's unfortunate, but perhaps there might have been a way for that first exemption to have been worded in a way that any of us who are new would read it with suspicion. I appreciate your explanation that all the health information has to be provided, but it could have been clearer in its wording. That wouldn't have caused Ms. Kadis and I to leap to...if not a conclusion, then a question.
Would it not always be that? Could you not always justify economically that it was a trade secret? Surely, if you have a new product, it's a trade secret. Wouldn't it always come out to be?